Magic mushroom therapy tested for depression
NCT ID NCT05227612
Summary
This small, early-stage study tested whether it is safe and practical to combine psilocybin (the active compound in 'magic mushrooms') with cognitive behavioral therapy (CBT) to treat major depression. Sixteen participants received two doses of psilocybin along with 12 therapy sessions. The main goals were to see if people could complete the combined treatment and to check if it helped reduce depression symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA Semel Institute
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.